FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
Corroborated by 1 source from 1 publisher
ushealth1d ago
TL;DR
According to finance.yahoo.com, sanofi (NASDAQ:SNY) is one of the best undervalued stocks under $50 to invest in now.